National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings, 55165 [2019-22382]
Download as PDF
<![CDATA[
55165
Federal Register / Vol. 84, No. 199 / Tuesday, October 15, 2019 / Notices
Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Medical
Countermeasures.gov.
SUPPLEMENTARY INFORMATION:
Type of Collection: OMB No. 0990–
0323—Extension—
Abstract: The Office of the Assistant
Secretary for Preparedness and
Response (ASPR), Office of the
Biomedical Advanced Research and
Development Authority (BARDA), is
requesting an approval on an extension
by OMB on a currently approved
information collection. The purpose of
this collection is, in order to route
product developers to the most
appropriate personnel within the
Department of Health and Human
Services (HHS), HHS collects some
basic information about the company’s
product through Medical
Countermeasures.gov. Using this
information and a routing system that
has been developed with input from
participating agencies within HHS,
including the Office of the Assistant
Secretary for Preparedness and
Response (ASPR), the Centers for
Disease Control and Prevention (CDC),
the Food and Drug Administration
(FDA), and the National Institutes of
Health (NIH), Medical
Countermeasures.gov routes the meeting
request to the appropriate person within
HHS. ASPR is requesting an extension
by OMB for a three-year clearance.
Type of respondent: Developers of
medical countermeasures to naturally
occurring and intentional public health
threats visit the site on a monthly basis.
ANNUALIZED BURDEN HOUR TABLE
Meeting Request ...................
Developers of medical countermeasures to
naturally occurring and intentional public
health threats..
245
1
10/60
41
Total ...............................
.......................................................................
........................
........................
........................
41
[FR Doc. 2019–22416 Filed 10–11–19; 8:45 am]
BILLING CODE 4150–04–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meetings
khammond on DSKJM1Z7X2PROD with NOTICES
Average
burden per
response
Respondents
(if necessary)
Terry Clark,
Asst Paperwork Reduction Act Reports
Clearance Officer,Office of the Secretary.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel: T32
Special Emphasis Panel.
Date: October 29, 2019.
VerDate Sep<11>2014
19:29 Oct 11, 2019
Jkt 250001
Number of
respondents
Number of
responses
per
respondent
Forms
(if necessary)
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Yasuko Furumoto, Ph.D.,
Scientific Review Branch, National Institute
of Arthritis and Musculoskeletal and Skin
Diseases, National Institutes of Health, 6701
Democracy Blvd., Room 820, Bethesda, MD
20817, 301–827–7835, yasuko.furumoto@
nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel: AMS
Member Conflict.
Date: October 31, 2019.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Room 818, Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Kathy Salaita, SCD, Chief,
Scientific Review Branch, DHHS/NIH/
NIAMS, One Democracy Plaza, Suite 800,
6701 Democracy Blvd. MSC 4872, Bethesda,
MD 20892, 301–594–5033, Kathy.Salaita@
nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel: Rare
Diseases SBIR Review Meeting.
Date: November 22, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Bethesda, MD 20892.
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Total burden
hours
Contact Person: Yin Liu, Ph.D., MD,
Scientific Review Branch, National Institute
of Arthritis and Musculoskeletal and Skin
Diseases, National Institutes of Health, 6701
Democracy Blvd., Room 824, Bethesda, MD
20817, 301–594–8919, liuy@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: October 8, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–22382 Filed 10–11–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
E:\FR\FM\15OCN1.SGM
15OCN1
]]>Agencies
[Federal Register Volume 84, Number 199 (Tuesday, October 15, 2019)]
[Notices]
[Page 55165]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-22382]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel: T32
Special Emphasis Panel.
Date: October 29, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Yasuko Furumoto, Ph.D., Scientific Review
Branch, National Institute of Arthritis and Musculoskeletal and Skin
Diseases, National Institutes of Health, 6701 Democracy Blvd., Room
820, Bethesda, MD 20817, 301-827-7835, [email protected].
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel: AMS Member
Conflict.
Date: October 31, 2019.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Arthritis and Musculoskeletal and
Skin Diseases, 6701 Democracy Boulevard, Room 818, Bethesda, MD
20892, (Telephone Conference Call).
Contact Person: Kathy Salaita, SCD, Chief, Scientific Review
Branch, DHHS/NIH/NIAMS, One Democracy Plaza, Suite 800, 6701
Democracy Blvd. MSC 4872, Bethesda, MD 20892, 301-594-5033,
[email protected].
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel: Rare
Diseases SBIR Review Meeting.
Date: November 22, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Arthritis and Musculoskeletal and
Skin Diseases, 6701 Democracy Boulevard, Bethesda, MD 20892.
Contact Person: Yin Liu, Ph.D., MD, Scientific Review Branch,
National Institute of Arthritis and Musculoskeletal and Skin
Diseases, National Institutes of Health, 6701 Democracy Blvd., Room
824, Bethesda, MD 20817, 301-594-8919, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: October 8, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-22382 Filed 10-11-19; 8:45 am]
BILLING CODE 4140-01-P
